Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$1.76 - $2.83 $241 - $387
137 New
137 $0
Q2 2023

Aug 14, 2023

SELL
$2.1 - $3.36 $74,718 - $119,548
-35,580 Reduced 85.35%
6,109 $14,000
Q1 2023

May 15, 2023

SELL
$2.13 - $3.6 $50,840 - $85,928
-23,869 Reduced 36.41%
41,689 $106,000
Q4 2022

Feb 14, 2023

SELL
$2.05 - $3.47 $69,429 - $117,521
-33,868 Reduced 34.06%
65,558 $164,000
Q3 2022

Nov 14, 2022

SELL
$0.63 - $5.47 $63,542 - $551,709
-100,861 Reduced 50.36%
99,426 $288,000
Q2 2022

Aug 15, 2022

SELL
$4.27 - $8.26 $601,322 - $1.16 Million
-140,825 Reduced 41.28%
200,287 $905,000
Q1 2022

May 16, 2022

BUY
$7.07 - $11.62 $870,592 - $1.43 Million
123,139 Added 56.49%
341,112 $2.74 Million
Q4 2021

Feb 14, 2022

BUY
$10.49 - $14.28 $2.29 Million - $3.11 Million
217,973 New
217,973 $2.54 Million

Others Institutions Holding SLGC

About SomaLogic, Inc.


  • Ticker SLGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 183,452,992
  • Description
  • SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...
More about SLGC
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.